Updated effectiveness of 13 valent pneumococcal conjugate vaccine in England and Wales and derivation of serotype specific correlates of protection

Nav

General Info

Geography

United Kingdom (GBR)

England, Wales

Coverage type

Subnational

Time period covered

01/2006 - 12/2013

Data type

Epi surveillance

Keywords

Lower respiratory infections, Pneumococcal vaccines

Citation

Authors

Andrews NJ, Kaye P, Slack MPE, Roalfe L, Zancolli M, Burbridge P, Pearce E, Miller E, Goldblatt D

Journal

Pneumonia (Nathan)

Volume

Publication year

2014

Suggested citation

Andrews NJ, Kaye P, Slack MPE, Roalfe L, Zancolli M, Burbridge P, Pearce E, Miller E, Goldblatt D. Updated effectiveness of 13 valent pneumococcal conjugate vaccine in England and Wales and derivation of serotype specific correlates of protection. In: Pneumonia: Special Issue (Volume 3, 2014). 9th International Symposium on Pneumococci and Pneumococcal Diseases; 2004 March 9-13; Hyderabad, India.

GHDx Entry last modified on: Jan 9, 2020

Header sites

Search form

Main menu

Updated effectiveness of 13 valent pneumococcal conjugate vaccine in England and Wales and derivation of serotype specific correlates of protection

Nav